TMED3 and hepatocellular carcinoma: In our present study, in terms of expression level, our observation made in breast cancer tissues were fully consistent with what’s been earlier reported in hepatocellular carcinoma [12] and prostate cancer [10] where TMED3 was found to be significantly up-regulated in cancer tissues compared with its normal controls.